Democratic Republic of Congo vs Myanmar: Access to anti-retroviral drugs, female (%)
Democratic Republic of Congo
78.0%
in 2024
Myanmar
78.0%
in 2024
Democratic Republic of Congo rank
60th
Myanmar rank
60th
Access to anti-retroviral drugs, female (%) over time
- Democratic Republic of Congo
- Myanmar
How they compare
Democratic Republic of Congo currently reports 78.0% against 78.0% in Myanmar, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Democratic Republic of Congo ranks 60th and Myanmar ranks 60th of 141 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 2.5% | 0.5% | Myanmar |
| 2010s | 25.7% | 39.2% | 13.5% | Myanmar |
| 2020s | 70.2% | 75.6% | 5.4% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Democratic Republic of Congo or Myanmar?
- Democratic Republic of Congo, at 78.0% against 78.0% in Myanmar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Democratic Republic of Congo and Myanmar?
- 0.0%, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Democratic Republic of Congo and Myanmar rank globally for access to anti-retroviral drugs, female?
- Democratic Republic of Congo ranks 60th and Myanmar ranks 60th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.